Pfizer and BioNTech submit application to USFDA for emergency use authorization of Omicron BA.4/BA.5-adapted bivalent vaccine booster for 5-11 year age

The companies have also initiated a Phase 1/2/3 study NCT05543616 to evaluate the safety, tolerability, and immunogenicity of different doses

Novartis unveils new focused strategy

Transformation to pure-play Innovative Medicines company nears completion

CellOrigin Biotech collaborates with Qilu Pharma to develop CAR-iMAC Cell Therapy

NATCO launches Chlorantraniliprole (CTPR) formulated product NATGEN

NATCO estimates the current market size of CTPR containing products in India to be over Rs. 2,000 crore.

Snazzy launches scan box and remote monitoring app to achieve 100% orthodontic goals

The startup plans to provide free technology to dental clinics upon registration.

Madhavbaug plans to foray in UAE, Europe & US

To set up 50 lifestyle modification centres across the UAE in the next 24 months

Lupin receives approval from US FDA for Diclofenac Sodium Topical Solution USP

Diclofenac Sodium Topical Solution USP, 2% w/w (RLD Pennsaid) had estimated annual sales of US $484 million in the US

Shilpa Medicare Hyderabad facility receives US FDA clearance

The facility is identified as a testing laboratory in numerous ANDAs filed by Shilpa Medicare Limited and its agreed parties

U.S. District Court rules in favor of Merck in Sitagliptin Phosphate patent lawsuit

Sitagliptin is an active ingredient in JANUVIA, JANUMET and JANUMET XR

KRSNAA leverages AI to deliver quality diagnostics to the rural hinterlands of India

Krsnaa Diagnostics plans to set up Tele-Pathology Reporting Centre in Pune